J. Marrero
12 works · 835 citations · h-index 4
Top works
- NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
- Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
- Pathogenesis of gastric metaplasia of the human duodenum: Role of Helicobacter pylori, gastric acid, and ulceration
- 994 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND PRIOR ANTI-TUMOR THERAPY: A SUBANALYSIS FROM THE SHARP TRIAL
- 1261 GP73, a resident golgi membrane protein, appears in sera of patients with viral liver disease and hepatocellular cancer
- Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib)
- Gideon (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [SOR]) 2nd Interim Analysis (IA): Subgroup Analysis by Disease Etiology
- 109 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPS
- DNA Quantification in Gastric Dysplasia
- SERUM-PROTEIN ALTERATIONS IN PANCREATIC CANCER PATIENTS AND THEIR USE FOR DISEASE CLASSIFICATION
- O35 PREDICTING SURVIVAL OF HIV-INFECTED PATIENTS WITH LIVER CANCER – THE SHILCA SCORE AND STAGING MODEL
- 669 VALIDATION OF THE MESIAH SCORE AS PREDICTOR OF SURVIVAL IN HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)